NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

16 hedge funds and large institutions have $9.62M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$65.7K
2 -$57K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.68M
2
$1.28M
3
$205K
4
$104K
5
$86K
6
$79K
7
$64K
8
$54K
9
$37K
10
$19K
11
$2K
12
$2K
13
$1K
14
$1K
15
$1K
16
$1K
17